Lenskart Share Price: Eyewear Giant Lists At 3% Discount To IPO Price - Details

Eyewear retailer Lenskart Solutions Ltd made a weak debut on stock exchanges on Monday, listing at a discount from its IPO price. On the NSE, shares were priced at Rs 395 apiece, down 1.74% from the IPO’s upper price band of Rs 402. Meanwhile, on the BSE, shares were listed at Rs 390, a 2.99% decline, putting the company’s post-listing market capitalization at Rs 67,659.94 crore.

The Rs 7,278-crore IPO had garnered robust investor interest, with the issue subscribed 28.26 times between October 31 and November 4, 2025. Despite strong primary market demand, the listing fell below expectations.

Lenskart IPO GMP Today 
Ahead of the listing, market trackers reported a GMP (grey market premium) of Rs 10, last updated on November 10, 2025, at 09:34 AM. With the price band of ₹402, the estimated listing price based on GMP was ₹412, implying an expected 2.49% gain per share.

Investor Impact: Loss Per Lot
For retail investors, the listing meant an initial paper loss. A standard lot of 37 shares was valued at Rs 14,615 per lot on listing day, compared to the theoretical IPO allotment value, signaling a drop in the initial investment.

Promoters and Investors Exit
The IPO included a fresh issue of Rs 2,150 crore and an offer-for-sale (OFS) of Rs 5,128.02 crore, allowing promoters and early investors to divest shares. Key promoters offloading their stake included Peyush Bansal, Neha Bansal, Sumeet Kapahi, and Amit Chaudhary.

Other investors selling shares under the OFS were Kedaara Capital Fund II LLP, SVF II Lightbulb (Cayman) Ltd, Macritchie Investments Pte Ltd, PI Opportunities Fund-II, Alpha Wave Ventures LP, and Schroders Capital Private Equity Asia Mauritius Ltd.

Disclaimer: The views expressed in this article are purely informational, and Republic Media Network does not vouch for, promote or endorse any opinions stated by any third party. Stock market and Mutual Fund investments are subject to market risks, and readers are advised to seek expert advice before investing in stocks, derivatives and Mutual Funds.